下载 RetinaRisk - v1.1

您听说过RetinaRisk - v1.1或Peloton - at home fitness, COVID Alert - Let’s protect each other, Tawakkalna (Covid-19 KSA), Hello Haylou Premium APK MOD APK, Fastic: Fasting App & Intermittent Fasting Tracker, Notify & Fitness for Mi Band，是类别健康与健身中最酷的应用之一。

当然，您知道并非所有游戏或应用程序都兼容所有手机。游戏或应用程序有时在您的设备上不可用，这取决于系统版本。Android操作系统，屏幕分辨率或国家/地区Google Play允许访问。这就是APKPanda提供Android APK文件供您下载且不遵守这些限制的原因。>
RetinaRisk - v1.1的最新版本为1.1，发行日期为2020-06-09，大小为17.3 MB。由Risk Medical Solutions开发，RetinaRisk - v1.1至少需要Android版本Android 5.0+。因此，如有必要，您必须更新手机。

负载量很大，大约有1000次下载。您可以根据需要更新已单独下载或安装在Android设备上的应用程序。更新应用程序使您可以访问最新功能，并提高应用程序的安全性和稳定性。

Know your risk of developing sight-threatening diabetic retinopathy.

The RetinaRisk app is designed for individuals with diabetes and is the first mobile application of its kind for diabetic retinopathy risk calculation.

The clinically validated algorithm allows users to assess their individualized risk of developing sight-threatening eye disease by inserting their risk profile (type and duration of diabetes, gender, existing retinopathy, HbA1c and blood pressure). The app enables users to analyze their risk results to learn about the key risk factors impacting their individualized results allowing them take mitigation actions to lower the risk. Find out whether you are in high or low risk of developing sight-threatening diabetic retinopathy. Find out what you should do to lower your risk and achieve target levels

Choose your language from English, Icelandic and German currently available. Spanish, French, Urdu and Arabic being released shortly

Access extensive educational material to learn more about diabetes and its many complications, including diabetic retinopathy

Track your progress over time using the trends feature that enables users to track their risk progression over time, set goals and export risk results.

The RetinaRisk app was developed by Risk Medical Solutions which is a scientific and academic based software house located in Iceland with over 30 years of experience in screening for diabetic retinopathy and treating diabetes.

Fixed usability issuesImproved interfaceBug fixes